New cancer drug targets Hard-to-Treat tumors in first human trial
Disease control
Recruiting now
This early-stage trial is testing a new drug called CTIM-76 for people with advanced ovarian, testicular, or endometrial cancers that have stopped responding to standard treatments. The study will enroll 80 participants to determine safe dosage levels and see if the drug helps co…
Phase: PHASE1 • Sponsor: Context Therapeutics Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC